✦ LIBER ✦

A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium

✍ Scribed by Zorzi, Alexandra P.; Bernstein, Mark; Samson, Yvan; Wall, Donna A.; Desai, Sunil; Nicksy, Darcy; Wainman, Nancy; Eisenhauer, Elizabeth; Baruchel, Sylvain

Book ID: 121187063
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 185 KB
Volume: 60
Category: Article
ISSN: 1545-5009
DOI: 10.1002/pbc.24694

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

344 A Phase I Study of Histone Deacetyla

344 A Phase I Study of Histone Deacetylase Inhibitor, SB939, in Pediatric Patients with Refractory Solid Tumors

✍ Zorzi, A.P.; Bernstein, M.; Samson, Y.; Wall, D.A.; Desai, S.; Wainman, N.; Eise 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB

404 POSTER A phase I study of oral admin

404 POSTER A phase I study of oral administration of the histone deacetylase (HDAC) inhibitor belinostat in patients (pts) with advanced solid tumors

✍ W. Kelly; D. Petrylak; G. Blumenschein; U. Lassen; P. Buhl Jensen; J. DeBono 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 64 KB

A phase I, first in man study of OSI-783

A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

✍ G. Goss; L. L. Siu; I. Gauthier; E. X. Chen; A. M. Oza; R. Goel; J. Maroun; J. P 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 233 KB

394 A phase I dose escalation and pharma

394 A phase I dose escalation and pharmacological study of the novel class I selective histone deacetylase inhibitor CHR-3996, in patients with advanced or treatment refractory solid tumours

✍ F. Eskens; L. van Doorn; D. Papadatos-Pastos; P. Debnam; M. Tall; M. Toal; L. Ho 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 47 KB